Cough, Cold and Allergy (Hay Fever) Remedies in Singapore
The pandemic led to a significant surge in sales of cough, cold, and allergy (hay fever) remedies in Singapore, particularly in 2022, as later COVID-19 variants exhibited symptoms similar to the common cold. However, in 2023 and 2024, with the country transitioning into the post-COVID-19 era, the overall growth rate of these remedies slowed considerably. Despite this, consumers remain proactive in managing their health at the first signs of illness, especially as they resume their social lives a...
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Singapore report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. Forecasts to 2029 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
Cough, Cold and Allergy (Hay Fever) Remedies in Singapore
Euromonitor International
January 2025
List Of Contents And Tables
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN SINGAPORE
KEY DATA FINDINGS
2024 DEVELOPMENTS
Preventive health mindset remains strong in 2024
Inconsistent air quality drives increased use of nasal sprays
Herbal remedies adapt to on-the-go lifestyles
PROSPECTS AND OPPORTUNITIES
Shift towards holistic health could drive demand for more natural or preventive remedies
Rising haze levels could have negative impact on respiratory health
Demand for antihistamines is expected to rise, in line with changing lifestyles
CATEGORY DATA
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2024
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2024
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2024-2029
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2024-2029
CONSUMER HEALTH IN SINGAPORE
EXECUTIVE SUMMARY
Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
Table 8 Life Expectancy at Birth 2019-2024
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2019-2024
Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification